Drug prices fall 3.1% in July; experts cite Biden-era law
July prescription drug prices fell 3.1% YoY, the largest drop in over 60 years. While the White House credited President Trump, experts like Harvard's Richard Frank and Vanderbilt's Stacie Dusetzina attribute the decline to the 2022 Inflation Reduction Act's Medicare negotiations.

*this image is generated using AI for illustrative purposes only.
Prescription drug prices in the United States fell 3.1% year-over-year in July, registering the sharpest annual decline in more than six decades according to Bureau of Labor Statistics data. The significant drop has sparked a political dispute over its primary driver, with the White House claiming credit for President Donald Trump while health economists point to legislation enacted under former President Joe Biden.
Policy Attribution Debate
Independent experts cited by The Washington Post indicated that the price reduction is more likely tied to Medicare drug-price negotiations mandated by the Inflation Reduction Act of 2022 rather than any policy from the Trump administration. Richard Frank, a professor emeritus of health economics at Harvard University, stated that if he had to bet on the cause, "it would be probably stuff around the Inflation Reduction Act." Frank noted that the law lowers prescription drug costs for people with Medicare and added that Trump's efforts "wouldn't be where I'd place my money."
Stacie Dusetzina of Vanderbilt University agreed with this assessment. She noted that the 10 drugs already negotiated under the law are widely used and "would likely be reflected in the prescription drug index," suggesting a direct correlation between the legislative mechanism and the CPI data.
White House Response
Despite expert consensus, the White House actively promoted the headline as evidence of Trump's success. On Friday, President Trump held up the Washington Post headline for cameras, declaring, "I told you that was going to happen."
The administration’s official social media accounts amplified the narrative. The White House posted a caption reading, "POV: you bring the receipts," alongside an image of the article. Press Secretary Karoline Leavitt also shared the image. Earlier on Thursday, White House Communications Director Steven Cheung posted a screenshot of the headline on X, writing, "All thanks to President Trump!" Cheung specifically cited "Most-Favored-Nation prescription drug pricing and TrumpRX" as making a huge difference for the American people, though he did not link to the original article in his post.
How might the ongoing political dispute over credit for drug price reductions influence future legislative cooperation on healthcare reform?
Will the success of Medicare drug-price negotiations under the Inflation Reduction Act encourage similar pricing mechanisms in private insurance markets?
What is the projected timeline for the next batch of drugs to enter federal price negotiations, and how will this impact overall CPI trends in the coming quarters?

























